These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22025384)

  • 21. Association of serum Cyr61 levels with peripheral arterial disease in subjects with type 2 diabetes.
    Feng B; Xu G; Sun K; Duan K; Shi B; Zhang N
    Cardiovasc Diabetol; 2020 Nov; 19(1):194. PubMed ID: 33222686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cysteine-rich, angiogenic inducer, 61 expression in patients with ovarian epithelial carcinoma.
    Lin Y; Xu T; Tian G; Cui M
    J Int Med Res; 2014 Apr; 42(2):300-6. PubMed ID: 24595148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pyk2 and Cyr61 at the cross-road of cAMP-dependent signalling in invasiveness and neuroendocrine differentiation of prostate cancer.
    Vitale G; Gentilini D; Abbruzzese A; Caraglia M
    Cancer Biol Ther; 2009 Feb; 8(3):243-4. PubMed ID: 19182531
    [No Abstract]   [Full Text] [Related]  

  • 24. Core 2 β-1, 6-N-acetylglucosaminyltransferase-1 expression in prostate biopsy specimen is an indicator of prostate cancer aggressiveness.
    Sato T; Yoneyama T; Tobisawa Y; Hatakeyama S; Yamamoto H; Kojima Y; Mikami J; Mori K; Hashimoto Y; Koie T; Ohyama C
    Biochem Biophys Res Commun; 2016 Jan; 470(1):150-156. PubMed ID: 26768364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cysteine-rich 61 (Cyr61): a biomarker reflecting disease activity in rheumatoid arthritis.
    Fan Y; Yang X; Zhao J; Sun X; Xie W; Huang Y; Li G; Hao Y; Zhang Z
    Arthritis Res Ther; 2019 May; 21(1):123. PubMed ID: 31113467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced expression of SRPK2 contributes to aggressive progression and metastasis in prostate cancer.
    Zhuo YJ; Liu ZZ; Wan S; Cai ZD; Xie JJ; Cai ZD; Song SD; Wan YP; Hua W; Zhong W; Wu CL
    Biomed Pharmacother; 2018 Jun; 102():531-538. PubMed ID: 29587239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum CYR61 Is Associated with Disease Activity in Graves' Orbitopathy.
    Woo YJ; Seo Y; Kim JJ; Kim JW; Park Y; Yoon JS
    Ocul Immunol Inflamm; 2018; 26(7):1094-1100. PubMed ID: 28548552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum Cyr61 is associated with clinical disease activity and inflammation in patients with systemic lupus erythematosus.
    Lin J; Li N; Chen H; Liu C; Yang B; Ou Q
    Medicine (Baltimore); 2015 May; 94(19):e834. PubMed ID: 25984669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential role of the OPG/RANK/RANKL axis in prostate cancer invasion and bone metastasis.
    Li X; Liu Y; Wu B; Dong Z; Wang Y; Lu J; Shi P; Bai W; Wang Z
    Oncol Rep; 2014 Dec; 32(6):2605-11. PubMed ID: 25333856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of CTGF and Cyr61 in colorectal cancer.
    Ladwa R; Pringle H; Kumar R; West K
    J Clin Pathol; 2011 Jan; 64(1):58-64. PubMed ID: 21081514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyr61/CCN1 is a tumor suppressor in human hepatocellular carcinoma and involved in DNA damage response.
    Feng P; Wang B; Ren EC
    Int J Biochem Cell Biol; 2008; 40(1):98-109. PubMed ID: 17698398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ghrelin O-acyltransferase (GOAT) enzyme is overexpressed in prostate cancer, and its levels are associated with patient's metabolic status: Potential value as a non-invasive biomarker.
    Hormaechea-Agulla D; Gómez-Gómez E; Ibáñez-Costa A; Carrasco-Valiente J; Rivero-Cortés E; L-López F; Pedraza-Arevalo S; Valero-Rosa J; Sánchez-Sánchez R; Ortega-Salas R; Moreno MM; Gahete MD; López-Miranda J; Requena MJ; Castaño JP; Luque RM
    Cancer Lett; 2016 Dec; 383(1):125-134. PubMed ID: 27693462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The matricellular protein CYR61 promotes breast cancer lung metastasis by facilitating tumor cell extravasation and suppressing anoikis.
    Huang YT; Lan Q; Lorusso G; Duffey N; Rüegg C
    Oncotarget; 2017 Feb; 8(6):9200-9215. PubMed ID: 27911269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CYR61 downregulation correlates with tumor progression by promoting MMP-7 expression in human gastric carcinoma.
    Maeta N; Osaki M; Shomori K; Inaba A; Kidani K; Ikeguchi M; Ito H
    Oncology; 2007; 73(1-2):118-26. PubMed ID: 18337624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells.
    Jones DZ; Schmidt ML; Suman S; Hobbing KR; Barve SS; Gobejishvili L; Brock G; Klinge CM; Rai SN; Park J; Clark GJ; Agarwal R; Kidd LR
    BMC Cancer; 2018 Apr; 18(1):421. PubMed ID: 29653561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sea cucumber extract TBL-12 inhibits the proliferation, migration, and invasion of human prostate cancer cells through the p38 mitogen-activated protein kinase and intrinsic caspase apoptosis pathway.
    Yuan L; Huang X; Zhou K; Zhu X; Huang B; Qiu S; Cao K; Xu L
    Prostate; 2019 Jun; 79(8):826-839. PubMed ID: 30889629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Silencing cAMP-response element-binding protein (CREB) identifies CYR61 as a tumor suppressor gene in melanoma.
    Dobroff AS; Wang H; Melnikova VO; Villares GJ; Zigler M; Huang L; Bar-Eli M
    J Biol Chem; 2009 Sep; 284(38):26194-206. PubMed ID: 19632997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and regulation of Cyr61 in human breast cancer cell lines.
    Tsai MS; Bogart DF; Li P; Mehmi I; Lupu R
    Oncogene; 2002 Jan; 21(6):964-73. PubMed ID: 11840342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sensitive Blood-Based Detection of Asbestos-Associated Diseases Using Cysteine-Rich Angiogenic Inducer 61 as Circulating Protein Biomarker.
    Bartkowiak K; Casjens S; Andreas A; Ačkar L; Joosse SA; Raiko I; Brüning T; Geffken M; Peine S; Johnen G; Weber DG; Pantel K
    Clin Chem; 2021 Jan; 67(2):363-373. PubMed ID: 33336248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Observed correlation between the expression levels of catalytic subunit, Cβ2, of cyclic adenosine monophosphate-dependent protein kinase and prostate cancer aggressiveness.
    Moen LV; Ramberg H; Zhao S; Grytli HH; Sveen A; Berge V; Skotheim RI; Taskén KA; Skålhegg BS
    Urol Oncol; 2017 Mar; 35(3):111.e1-111.e8. PubMed ID: 27838142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.